Target preparation one-cycle target labelling assay -cRNA synthesis 2μg of total RNA was converted to cDNA via first and second strand synthesis using the GeneChip® Expression 3'-Amplification One-Cycle cDNA Synthesis kit, in conjunction with the GeneChip® Eukaryotic Poly-A RNA Control Kit. Cleanup of the double-stranded cDNA was carried out using the GeneChip® Sample Cleanup Module. Biotin labeled cRNA was synthesised from the double-stranded cDNA using the GeneChip® Expression 3'-Amplification In Vitro Transcription (IVT) Labeling Kit. Unincorporated NTPs were removed with the GeneChip® Sample Cleanup Module. cRNA quality was assessed using an Eppendorf Biophotmeter and an Agilent 2100 bioanalyzer.
Fragmented cRNA generation
25μg of cRNA generated in the IVT reaction was fragmented using 5X Fragmentation buffer and RNasefree water contained within the GeneChip® Sample Cleanup Module. The fragmentation reaction was carried out at 94°C for 35 mins to generate 35-200 base fragments for hybridisation. The fragmented cRNA quality was assessed using an Agilent 2100 bioanalyzer.
Affymetrix hybridisation protocol
Prior to hybridization, the adjusted cRNA yield in the fragmentation reaction was calculated to account for carryover of total RNA in the IVT reaction. 15μg of fragmented cRNA was made into a hybridisation cocktail in accordance with the Affymetrix technical manual corresponding to a 49 format (standard) /64 format array. The hybridisation cocktail was added to the appropriate array and hybridised for 16hrs at 45°C.
Data analysis and generation of gene groups
The filter system used was the flag filter: the starting gene list was all genes. In the first filter, genes displaying a match in terms of their regulation, in OE21 and OE33 cells were retained [ Supplementary Figure 1] . Genes that have conflicting regulation i.e. are down regulated in the OE21 cell line but up regulated in the OE33 cell line are discarded. 15805 genes passed this filter, and these comprise the initial 'common to Group A' (CA) gene list. Likewise, a similar analysis of genes in the OE19 and KYSE450 cells revealed a gene list of 16346 common genes, comprising the initial 'common to Group B' (CB) gene list. These two gene lists were further analysed for patterns that were consistently different between CA and CB. This list was filtered, so that only those genes with a differential in expression of three fold or higher, form the final list of ~ 230 genes. In addition, 30 genes were expressed in CA, and not expressed in CB (or vice versa). In total, 260 genes showed greater than a 3 fold difference in expression between the groups. to untransfected (left lanes) and scrambled control (right lanes) was assessed by Western blot. C. Analysis of cellular morphology by light microscopy (40x magnification) compared vesicle accumulation (black arrowheads) in scrambled (upper panels) and ISG15 siRNA (lower panels) cells treated with either rapamycin (left panels) or VPA (right panels). D. Autophagic flux was assessed by measuring LC3 II levels in untransfected (left lanes), scrambled control (right lanes) and ISG15 siRNA (middle lanes) cells following 24 hr treatment with chloroquine (10 μM) in combination with rapamycin or E. in combination with VPA. LC3 II levels were normalised to β-actin and presented graphically as integrated intensities. F. Induction of autophagy was confirmed by morphological analysis (black arrowheads, magnification 40 X) following transfection with scrambled control (upper panels) or ISG15 (lower panels) siRNA in cells treated with chloroquine in combination with rapamycin (left panels) or in combination with VPA (right panels). 4) and scrambled control (lanes 2 & 5) was assessed by Western blot. LC3 I & II bands were quantified, normalised to β-actin and presented as integrated intensities. C. (i) Cyto-ID autophagy detection kit was used to assess autophagosome formation by ISG15 siRNA alone (orange overlay) relative to scrambled (green overlay) (**p < 0.005) or untreated cells (grey filled histogram). Autophagic flux was assessed by measuring autophagosome formation, following treatment with chloroquine (10 μM) of untransfected (black overlay), scrambled control (blue overlay) and ISG15 siRNA (red overlay) cells (**p < 0.005). (ii) Enhanced autophagosome formation was observed in ISG15 depleted cells treated with a combination of 5-FU and chloroquine (red overlay) relative to untransfected (green overlay) and scramble control (blue overlay) cells (**p < 0.005). D. Following drug removal, a colony formation assay was carried out to determine the ability of ISG15 depleted cells to recover, relative to scramble control cells. Colonies were stained using Rapi-diff and quantified using the Odyssey Infra-red imaging system. Triplicate data is presented as integrated intensity ± SEM (*p < 0.05). Cyto-ID assay was used to confirm autophagy induction by UBE2L6 siRNA alone (orange overlay) relative to scrambled (green overlay) (**p < 0.005) or untransfected cells (grey filled histogram). Autophagic flux was assessed by measuring autophagosome formation, following treatment with chloroquine of untransfected (black overlay), scrambled control (blue overlay) and UBE2L6 siRNA (red overlay) cells (***p < 0.0005). E. Enhanced autophagosome formation was observed in UBE2L6 depleted cells treated with 5-FU (red overlay) relative to untransfected (black overlay) and scramble control (blue overlay) cells (**p < 0.01). F. Induced autophagic flux was confirmed in UBE2L6 depleted cells treated with a combination of 5-FU and chloroquine (red overlay) relative to untransfected (green overlay) and scramble control (blue overlay) cells (***p < 0.0001). G. Cells were treated with 5-FU for 48 hr. Following drug removal, a colony formation assay was carried out to determine the ability of UBE2L6 depleted cells to recover, relative to scramble control cells. Colonies were stained using Rapi-diff and quantified using the Odyssey Infra-red imaging system. Triplicate data is presented as integrated intensity ± SEM (*p < 0.05).
